Durham, United Kingdom · Founded 2014 · Privately Held (backing)
Operator of a biopharmaceutical company intended to treat lung disease with excess mucus and mucus plugs. Aer Therapeutics is based in Durham, United Kingdom and was founded in 2014. It was valued at $58 million at a debt round in Mar 2025, the last priced event on record. It has raised $48 million across 2 recorded rounds; the latest was a $5 million early-stage round in Jan 2025.
PMV mark · valuation
$58.0M
Oct 2026
Priced at
a debt round
Mar 2025
Total raised
$48.0M
Last round
Early Stage VC
Jan 2025
Team — not yet on record
No current team members for Aer Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Aer Therapeutics with a free account
·Watch Aer Therapeutics: the Monday email on marks, rounds and moves
